CamOncology Leadership
Ian Fraser (Chief Operating Officer)
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Ian Fraser (Chief Operating Officer)
Ian Fraser. A seasoned operational leader. He has worked in Clinical Operations in both Pharmaceutical and Clinical Research Organisations for 30 years.
Ian has significant experience in Oncology clinical research and was previously COO at Bionical Emas and Clinipace.
Bill Robinson (Non Exec Chairman)
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Ian Fraser (Chief Operating Officer)
Bill Robinson. Formerly COO of UCB, a Brussels-based global biopharmaceutical company. 35 years at Eli Lilly, one of the leading US pharmaceutical companies, where he held a number of senior international management roles in Sales and Marketing, General Management, and Research and Development. Prior to his retiring from Lilly he was VP for US Sales and Marketing
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Professor Melinda Duer FRSC (Founder). Melinda is Professor of Biological and Biomedical Chemistry at the Yusuf Hamied Department of Chemistry, University of Cambridge.
Her research team has pioneered the use of physical sciences technology to probe and understand the molecular structure of the extracellular matrix.
She is one of the leading experts in the role of the ECM in cancer technology.
James Harrison (Director)
David Buckeridge (Director)
Professor Melinda Duer FRSC (Founder & Non Exec Director)
Founder and Group CEO of Cycle Group Holdings Ltd, which includes Cycle Pharmaceuticals – a $50m net sales rare disease pharmaceutical business a clinical-stage oncology biotech that has licensed projects from University of Cambridge and Harvard Medical School.
Former MD of TowerBrook Capital Partners and Partner of Soros Fund Management.
David Buckeridge (Director)
David Buckeridge (Director)
David Buckeridge (Director)
David has over 35 years of operational management experience in the life science and agribusiness industries.
Group CEO of Advanta BV, the largest independent agronomic seed business in the world at that time.
Former Partner of Paine Schwartz, a food chain focussed private equity business.
20 years at AZ in a variety of management positions globally.
Sean Sutcliffe (Director)
David Buckeridge (Director)
David Buckeridge (Director)
Sean Sutcliffe brings experience of building technology enabled companies over 25 years.
He is Chief Executive of Oxford Space Systems, a space deployable antenna business and non executive director of KEIT Spectrometers.
He is a Chartered Engineer with an Engineering Science degree from Cambridge University.
Barbara Gibbes (Director)
Barbara Gibbes (Director)
Barbara Gibbes (Director)
Barbara is currently CFO at Slaughter and May.
Prior to this she was CFO at Diploma Plc, a FTSE-100 industrial distributor and before then held senior finance roles across a number of sectors in FTSE-listed businesses, including professional services, leisure and property.
She has a strong grounding in professional services, having started
Barbara is currently CFO at Slaughter and May.
Prior to this she was CFO at Diploma Plc, a FTSE-100 industrial distributor and before then held senior finance roles across a number of sectors in FTSE-listed businesses, including professional services, leisure and property.
She has a strong grounding in professional services, having started her career at Deloitte where she was a Director in Audit and Transaction Services.
Barbara holds a degree in Arabic with Economics from Durham University.